Wei Wen Hou
Direktor/Vorstandsmitglied bei MingMed Biotechnology Co., Ltd.
Profil
Wei Wen Hou is currently an Independent Non-Executive Director at MingMed Biotechnology Co., Ltd.
He completed his undergraduate degree at The Chinese University of Hong Kong in 1997 and earned an MBA from The Hong Kong University of Science & Technology in 2007.
Aktive Positionen von Wei Wen Hou
Unternehmen | Position | Beginn |
---|---|---|
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Direktor/Vorstandsmitglied | - |
Ausbildung von Wei Wen Hou
The Chinese University of Hong Kong | Undergraduate Degree |
The Hong Kong University of Science & Technology | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |